Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
12 December 2023
A General Meeting of the Shareholders of Doctor Care Anywhere Group Plc
Doctor Care Anywhere Group PLC (ASX:DOC, “Doctor Care Anywhere” or “the Company”) encloses its
Notice of a General Meeting (“Meeting”) of Shareholders and Proxy Form which will be distributed to
holders of ordinary shares in the Company (Shares) and Voting Intention Form which will be
distributed to holders of CHESS Depositary Interests representing underlying Shares (CDIs) on or about
12 December 2023.
General Meeting of Shareholders
Details of the Meeting are set out below:
Date:
Time:
Venue:
Virtual Link:
Thursday, 4 January 2024
18:30 AEDT, 07:30 GMT
The offices of Crowe U.K. LLP, 55 Ludgate Hill, London,
EC4M 7JW
or
Online using the below link:
https://meetnow.global/MMYNSG4
The Meeting is a hybrid meeting which gives Securityholders the opportunity to either (a) attend the
Meeting in person at the location noted in the table above or (b) attend the Meeting virtually using
the link provided in the table above.
Shareholders – How to attend the Meeting virtually
Using a computer, tablet or smartphone, Shareholders and proxyholders will be required to login at
the above link. Online registration will open from 18:00 AEDT or 07:00 GMT.
To participate in the Meeting online follow the instructions below.
1. Click on ‘Join Meeting Now’.
2. Select “I am a shareholder/proxyholder”
3. Enter your SRN/HIN. Proxyholders will need to contact Computershare on
+61 3 9415 4024 one hour prior to the Meeting to obtain their unique email invitation link.
4. Enter your postcode registered to your holding if you are an Australian Shareholder. If you
are an overseas Shareholder select the country of your registered holding from the dropdown list.
5. Accept the Terms and Conditions and ‘Click Continue’.
You can view the Meeting live, ask questions verbally or via a live text facility and if you are a
Shareholder, you can cast votes at the appropriate times while the Meeting is in progress.
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
CDI Holders – How to attend the Meeting virtually
If you participate in the Meeting online as a CDI Holder (and have not appointed yourself or someone
else as CDN’s proxy), you can log in to the Meeting by:
1. Click on ‘Join Meeting Now’.
2. Select “I am a guest”
3. Entering your name and email address. (Note that CDI Holders may not vote online at the
Meeting unless they have nominated themselves to be appointed as CDN’s proxy prior to the
Meeting.)
In accordance with Listing Rule 3.17, attached is a copy of the following documents:
1.
2.
3.
4.
5.
Letter to Securityholders with respect to the General Meeting
Notice of Meeting;
Voting Intention Form (if applicable);
Proxy Form (if applicable): and
Guidance Notes
You are encouraged to complete the Proxy Form if you are a Shareholder and the Voting Intention
Form if you are CDI Holder, and submit the applicable form as soon as possible as per the instructions
circulated to Securityholders with the enclosed notice.
The Company’s latest financial reports for 2023 are available on the Investor section of the Company’s
website at www.doctorcareanywhere.com/investors and on the ASX website.
Further disclosures on the business of the Meeting are also available on the Investor section of the
Company’s website at www.doctorcareanywhere.com/investors and on the ASX website.
This ASX release has been authorised for release by the Board of Directors.
- ENDS –
About Doctor Care Anywhere
Doctor Care Anywhere Group PLC is one of the UK’s largest private providers of telehealth services. The
Company works with insurers, healthcare providers and corporate customers to connect patients to a
range of digitally-enabled telehealth services on its proprietary platform. DCA is committed to
delivering the best possible patient experience and clinical care through digitally enabled, joined up,
evidence-based pathways.
Further Information:
James Warren
Acting CFO
james.warren@doctorcareanywhere.com
Share Registrar
Computershare Investor Services Pty Limited
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
GPO Box 242 Melbourne
Victoria 3001 Australia
Enquiries(Overseas) +61 (03) 9415 4000
Enquiries(Australia) 1300 850 505
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
12 December 2023
A General Meeting of the Shareholders of Doctor Care Anywhere Group Plc
Dear Doctor Care Anywhere Shareholder,
Notice of a General Shareholders’ Meeting
NOTICE IS HEREBY GIVEN that a GENERAL MEETING ( the “Meeting”) of Doctor Care Anywhere Group
PLC (ASX:DOC, “Doctor Care Anywhere” or “the Company”) will be held on 4 January 2024 at 18:30
AEDT and 07:30 GMT.
Doctor Care Anywhere Group PLC is a UK-based company that is listed on the Australian Securities
Exchange. Accordingly, the Meeting will be conducted as a hybrid meeting whereby Securityholders
can attend either in person at the offices of Crowe U.K. LLP, 55 Ludgate Hill, London, EC4M 7JW , or
via the online platform provided by our share registry at https://meetnow.global/MMYNSG4.
The timing of the Meeting is necessitated by the timezone differences between the UK and Australia
where our Securityholders are primarily based. It is intended to allow the participation of
Securityholders from both countries.
We recognise the importance of you having the opportunity to communicate your views to us and
value your participation, so we have explained how this will work in the information appended to this
Notice.
The Notice of Meeting and associated information, along with voting information, the Proxy Form and
the Voting Intention Form, contain all the information required.
We will seek to ensure that everyone who has a right to speak at the Meeting is able to do so.
How you can participate virtually
The online platform will allow you to listen to the proceedings of the Meeting, ask questions of the
Board and, if you are a Shareholder, vote in real time. You will need a desktop, mobile or tablet device
with internet access, and you will need to provide your details (including Shareholder Reference
Number (SRN) or Holder Identification Number (HIN)) in order to be verified as a security or proxy
holder of the Company.
Alternatively, you can register as a visitor of the Meeting.
We recommend logging in to the online platform 10 minutes before the commencement of the
Meeting using the instructions provided in the Notice of the Meeting.
Instructions for joining the Meeting will also be published on the Doctor Care Anywhere website prior
to the Meeting. The webcast will also be archived on DOC’s website for you to access at your
convenience.
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
Physical Attendance
For Securityholders attending the Meeting in person, we recommend arriving 20 minutes before the
commencement of the Meeting to enable registration processes for both our host and registry service
to be completed. Registration opens from 18:00 AEDT and 07:00 GMT on the day of the Meeting.
Securityholder questions
Although we will allow Securityholders to submit questions online during the Meeting, Securityholders
are encouraged to submit questions, to the Company, ahead of the Meeting and no later than 17:00
AEDT or 17:00 GMT (for UK based securityholders) on 2 January 2024. Please submit your advance
questions by emailing company.secretary@doctorcareanywhere.com. Further details are set out in
the appended information sheet.
Securityholders will also be given a reasonable opportunity to ask questions related to the business of
the Meeting or the Company’s operations at the end of the Meeting. If you would like to ask a question
during the Meeting, please register as a Securityholder or proxyholder and provide your HIN or SRN
and postcode.
Should you have any questions regarding your security holding or the upcoming Meeting, please
submit a question to Computershare on www.investorvote.com.au or contact the registry standard
phone lines (noted on voting intention form) 1300 850 505 (within Australia) or +61 3 9415 4000
(outside Australia).
Shareholders – How to submit votes ahead of the Meeting
If you are a Shareholder entitled to vote at the Meeting (ie. your name is entered in the Company’s
register of Shareholders by 18:30 AEDT, 07:30 GMT on 2 January 2024), the Company will provide you
with a personalised Proxy Form together with the notice of Meeting. The completed Proxy Form must
be received by the Company at the address shown on the Proxy Form not less than 48 hours before
the time fixed for the Meeting or an adjournment thereof. As such, for your proxy appointment to be
effective, your completed Proxy Form must be received by the Company by no later than 18:30 (AEDT)
or 07:30 (GMT) Tuesday, 2 January 2024.
CDI Holders Voting – How to submit votes ahead of the Meeting
CDI Holders can indicate their voting preferences to CHESS Depositary Nominees Pty Limited (“CDN”)
in advance of the Meeting by completing the Voting Intention Form attached to the Notice and
provide specific instructions on how their vote is to be exercised on each item of business. CDN must
follow your instructions. The Voting Intention Form needs to be received at the address shown on the
form not less than 96 hours (excluding Saturdays, Sundays and holidays) before the time fixed for the
Meeting or an adjournment thereof. CDI Holders cannot vote at the Meeting either online or in person
during the Meeting.
I look forward to welcoming you to our Meeting on 4 January 2024.
Yours faithfully,
John Stier
Chairman
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
12 December 2023
Notice of A General Meeting of Shareholders
NOTICE IS HEREBY GIVEN that a GENERAL MEETING of the Shareholders of Doctor Care Anywhere
Group Plc (“the Company”) will be held by way of a hybrid Meeting on Thursday, 4 January 2024
commencing at 18:30 AEDT or 07:30 GMT at the offices of Crowe U.K. LLP, 55 Ludgate Hill, London,
EC4M 7JW and virtually at https://meetnow.global/MMYNSG4. Physical attendees are encouraged to
arrive at least 20 minutes before the commencement of the Meeting to enable registration processes
for both our host and registry service to be completed.
If attending the Meeting virtually, all Securityholders will be able to participate and ask questions
however only Shareholders will be able to cast their vote whilst the Meeting is in progress either in
person or via the online platform. CDI Holders are unable to cast their vote during the Meeting either
in person or via the online platform.
Securityholders are strongly encouraged to cast their vote by proxy prior to the Meeting in accordance
with the instructions provided to ensure their votes are counted. Shareholders can use the Proxy
Form and CDI Holders can use the Voting Intention Form, to cast or direct their votes ahead of the
Meeting.
All resolutions to be considered at the Meeting will be decided by a poll based on proxy votes
received prior to the Meeting and votes cast during the Meeting.
For Securityholders wishing to attend virtually, further information on how to participate and for
Shareholders, how to vote during the Meeting, via the online platform is set out in the virtual Meeting
guide appended to this Notice.
The Business of the Meeting appended to this Notice provides information on the matters to be
considered at the Meeting. The Business of the Meeting, Explanatory Memorandum, Voting Intention
Form and Proxy Form are part of this Notice.
Notes
1. To be entitled to vote, a Shareholder must first have their name entered in the Company’s
register of Shareholders by 18:30 AEDT, 07:30 GMT on 2 January 2024, if this Meeting is
adjourned, at the close of business on the day two business days prior to the adjourned
Meeting. Changes to entries on that register after that time shall be disregarded in
determining the rights of any Shareholder to participate and vote at the Meeting.
2. Shareholders
who
have
queries
about
the
Meeting
should
email
company.secretary@doctorcareanywhere.com or submit a question to Computershare on
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
www.investorvote.com.au. If you have a Meeting day query, you can also contact
Computershare by calling their standard phone number on 1300 850 505 (within Australia) or
+61 3 9415 4000 (outside Australia)..
Business of the Meeting
Set out below are the resolutions that will be considered and if thought fit, passed at the Meeting.
1. Ordinary Resolution to be voted on by eligible Shareholders – Approval authorising the
allotment of Shares and Share Rights in connection with the Convertible Loans
THAT, in accordance with Section 551 of the Companies Act 2006 (the “Act”) the directors
of the Company be generally and unconditionally authorised to exercise all powers of the
Company to allot shares in the capital of the Company (“Shares”), such Shares having the
respective rights and being subject to the conditions set out in the articles of association of
the Company from time to time (“Articles”), and/or to grant rights to subscribe for, or to
convert any security into Shares (“Share Rights”) to be issued pursuant to a convertible loan
agreement(s) entered into by the Company on or around the date of this notice of Meeting
up to a maximum aggregate nominal amount of approximately £38,708.65 provided that:
•
•
unless renewed, varied or revoked by the Company, the authority granted under
this resolution shall expire five years after the passing of this resolution; and
in accordance with section 551(7) of the Act, the Company may, before such expiry
as noted above, make an offer or agreement which would require Shares to be
allotted or Share Rights to be granted after such expiry and the Directors may allot
such Shares or grant such Share Rights (as the case may be) in pursuance of such
offer or agreement notwithstanding that the authority conferred by this resolution
has expired.
The authority granted under this resolution is in addition to all previous allotment authorities
granted to the Company, to the extent they remain un-utilised.
Board Recommendation and Chairman’s Voting Intention for Item 1
The Directors recommend that all eligible voting Securityholders vote in favour of this Item 1. It is the
intention of the Chairman to vote undirected proxies in favour of this item 1.
2. Ordinary Resolution to be voted on by eligible Shareholders - Approval of the issue of
Convertible Notes under the Convertible Note Placement for the purposes of ASX Listing Rule
7.1.
THAT, approval be given for the purposes of ASX Listing Rule 7.1, and for all other purposes,
for the agreement to issue, and the issue of, convertible notes by the Company of up to a
principal value of approximately £10,600,000 (“Convertible Notes”), and for the issue of
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
CDIs/Shares on conversion of those Convertible Notes, on the terms and conditions set out in
the Explanatory Memorandum.
A voting exclusion statement applies to this resolution. Please see below.
It should be noted that this resolution 2 is conditional on resolution 1 having been approved by
Shareholders. If resolution 1 is not approved by Shareholders at the Meeting, then this resolution 2
will also not be approved and will withdrawn as a resolution from the notice of Meeting.
Board Recommendation and Chairman’s Voting Intention for Item 2
The Directors recommend that all eligible voting Securityholders vote in favour of this Item 2. It is the
intention of the Chairman to vote undirected proxies in favour of this item 2.
3.
Ordinary Resolution to be voted on by Shareholders - Approval of the issue of Share Options
pursuant to the Consultancy Agreement and allotment of Shares on exercise of those Share
Options
THAT:
• in addition to any authority granted under resolution 1, the Directors be and are
hereby generally and unconditionally authorised, pursuant to section 551 of the Act,
to exercise all the powers of the Company to allot 3,500,000 shares in the Company
in connection with the Share Options to be issued as the agreed remuneration
structure under the Consultancy Agreement (the “Agreement”) and to grant rights to
subscribe for said shares in the Company comprising equity securities, as defined in
section 560 of the Act, with an aggregate nominal value of up to £584.50, and that the
Board may impose any limits or restrictions and make any arrangements which it
considers necessary or appropriate to deal with legal, regulatory or practical problems
in, or under the laws of, any territory or the requirements of any regulatory body or
stock exchange. This authority for the purpose of section 551 of the Act, shall be valid
for a period not exceeding five years from the date of this resolution unless renewed
before it expires; and
•
Shareholders also hereby approve the issue of the Share Options and CDIs/Shares
issued on exercise of those Share Options, under and for the purposes of ASX Listing
Rule 7.1 and for all other purposes, on the terms and conditions set out in the
Explanatory Memorandum.
Board Recommendation and Chairman’s Voting Intention for Item 3
The Directors recommend that all eligible voting Securityholders vote in favour of this Item 3. It is the
intention of the Chairman to vote undirected proxies in favour of this item 3.
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
4. Special Resolution to be voted on by Shareholders - The dis-application of pre-emption rights
under s.571 of the Companies Act 2006
THAT, if resolution 1 and 3 are passed, the Directors be authorised to grant rights to subscribe for or
to convert any equity security (as defined in the Act) into shares in the Company for cash under the
authority given by those resolutions as if section 561 of the Act did not apply to any such allotment
offer and that such authority is limited to any such allotment and/or sale of equity securities in
connection with an offer or issue by way of rights or other pre-emptive offer or issue, open for
acceptance for a period fixed by the Directors, to holders of CDIs or Shares (other than the Company)
on the register on any record date fixed by the Directors in proportion (as nearly as may be) to the
respective number of securities deemed to be held by them, subject to such exclusions or other
arrangements as the Directors may deem necessary or expedient in relation to fractional entitlements,
legal or practical problems arising in any overseas territory, the requirements of any regulatory body
or stock exchange or any other matter whatsoever.
Board Recommendation and Chairman’s Voting Intention for Item 4
The Directors recommend that all eligible voting Securityholders vote in favour of this Item 4. It is the
intention of the Chairman to vote undirected proxies in favour of this item 4.
5. Other Business
To consider any other business which may properly be brought before the Meeting in accordance with
the Company’s Articles of Association and the Companies Act 2006.
Voting Exclusion Statement for Resolution 2 and 3
In accordance with ASX Listing Rule 14.11, the Company will disregard any votes cast in favour of each
of resolution 2 and 3 by or on behalf of any person who is expected to participate in, or who will obtain
a material benefit as a result of, the proposed issue (except a benefit solely by reason of being a holder
of ordinary securities in the Company) and any associate of those persons.
However, this does not apply to a vote cast in favour of resolution 2 and 3 by:
a) a person as proxy or attorney for a person who is entitled to vote on resolution 2 or 3, in
accordance with the directions given to the proxy or attorney to vote on the applicable
resolution in this way;
b) the chair of the Meeting as proxy or attorney for a person who is entitled to vote on resolution
2 or 3, in accordance with a direction given to the chair to vote on the applicable resolution
as the chair decides; and
c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of
a beneficiary provided the following conditions are met:
i.
the beneficiary provides written confirmation to the holder that the beneficiary is not
excluded from voting, and is not an associate of a person excluded from voting, on
resolution 2 or 3; and
ii.
the holder votes on resolution 2 or 3 in accordance with directions given by the
beneficiary to the holder to vote in that way.
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
EXPLANATORY MEMORANDUM
This Explanatory Memorandum is to be read in conjunction with the accompanying Notice of General
Meeting.
Purpose
The purpose of this Explanatory Memorandum is to provide Securityholders with an explanation of
the business of the Meeting and of the resolutions to be proposed and considered at the Meeting of
the Company to be held on 4 January 2024 at 18:30 AEDT and 07:30 GMT and to allow Shareholders
to determine how they wish to vote on those resolutions.
Shareholder should read the Notice of Meeting and this Explanatory Memorandum in full before
deciding how to vote.
Capitalised Terms
Capitalised terms used in this Explanatory Memorandum have the meanings given to them in the
Glossary unless otherwise defined.
RESOLUTIONS 1 and 2 – Approval of the issue of Convertible Notes under the Convertible Note
Placement and allotment and issue of CDIs/Shares on conversion of the notes
Background
The Company has entered into Convertible Note Agreements (Convertible Note Placement) with AXA
PPP Healthcare Group Limited (AXA Health), Axia Investments Ltd (Axia), and certain other investors
under which the Company has agreed to issue convertible notes (Convertible Notes) worth a total of
approximately £10.6m (approximately A$20.3m), subject to Shareholder approval being obtained for
this Resolution 1 and 2. The Company will use proceeds raised from the Convertible Note Placement
to strengthen its balance sheet by the repayment in full of the Company’s existing £10m loan from
AXA Health (AXA Loan).
Under the Convertible Note Placement, AXA Health has agreed to subscribe for approximately £5.41m
worth of Convertible Notes, Axia has agreed to subscribe for approximately £5.2m worth of
Convertible Notes and other investors have agreed to subscribe for an aggregate of approximately
£0.04m worth of Convertible Notes, to raise a total of approximately £10.6m, with £10.4m being used
to repay the AXA Loan including accrued interest. The remaining £0.2m will be used by the Company
to pay for transaction costs and working capital.
The Company considers that the refinancing of the AXA Loan as a result of the Convertible Note
Placement, has the following benefits:
•
•
•
the Convertible Notes will extend the term of the Company’s debt facilities to 31 December
2027, compared with the current AXA Loan currently becoming repayable from November
2023 and fully repayable on 30 November 2026;
removes the need for the Company to make quarterly repayments of the AXA Loan; and
frees up the Company’s cash resources which can be invested in the operations and growth
of the business. In addition, the Company expands its relationship with AXA, its largest
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
customer, as AXA becomes a potential significant investor in the Company (if it elects to
convert its Convertible Notes), evidencing the strength of our relationship.
Below is a table setting out the effect of the Company’s entry into the Convertible Note Agreements
on the capital structure of the Company.
Number on issue on the date
of this Notice of Meeting and
immediately prior to entry
into the Convertible Note
Agreements
Number on issue on completion
of the Convertible Note
Placement and assuming full
conversion of the Convertible
Notes (on a fully diluted basis)1
CDIs
366,771,846
598,560,134
Options
12,658,548
16,158,548
Deferred Shares
99,600
99,600
Convertible Notes
0
Approximately 10,640,000
Convertible Notes with a principal
value of approximately £10.6m
Note: this table is prepared on the basis that all Shares are held as CDIs
Note 1: assuming Securityholder approval to issue the Convertible Notes and issue the Share Options, has been
obtained at the Company’s general meeting proposed to be held in January 2024
Further to the above, the below table shows the potential securityholdings that the investors in the
Convertible Note Placement may hold as a result of their Convertible Notes.
Number
of CDIs
held on
date of
this
Notice of
Meeting
% of
CDIs
held on
the date
of this
Notice
of
Meeting
Number of
Convertible
Notes
acquired
under the
Convertible
Note
Placement
Number of CDIs held
following completion
of the Convertible
Note Placement and
assuming full
conversion of the
Convertible Notes (on
a fully diluted basis)1
% of CDIs held
following completion
of the Convertible
Note Placement and
assuming full
conversion of the
Convertible Notes (on
a fully diluted basis)1
Axia
0
0
5,194,960
113,174,860
18.9%
AXA Health
0
0
5,407,101
117,796,472
19.7%
0
37,500
816,957
0.1%
Other
Convertible
Note investors
Note: this table is prepared on the basis that all Shares are held as CDIs
Note 1: assuming Securityholder approval to issue the Convertible Notes and issue of Share Options has been
obtained at the Company’s general meeting proposed to be held in January 2024
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
Resolution 1 – Approval of the allotment of Shares and Share Rights in connection with the
Convertible Loans for the purpose of the Companies Act 2006 (UK)
Companies Act approval (the “Act”)
Under the Companies Act 2006 (UK), shareholder approval must be sought before the Directors of a
UK public company can exercise the power of the company to allot shares in company. This authority
can be granted by the passing of an ordinary shareholder resolution under Section 551 of the Act.
As such, the Company is seeking Shareholder approval for the purposes of Section 551 of the Act of
the allotment and issue of the Shares and Share Rights in connection with the Convertible Notes under
the Convertible Note Placement.
Resolution 2 – Approval of the issue of Convertible Notes under the Convertible Note Placement
and issue of CDIs/Shares on conversion of the notes for the purpose of ASX Listing Rule 7.1
ASX Listing Rule 7.1
The issue of the Convertible Notes, is conditional on Shareholder approval at this Meeting for the
purposes of Listing Rule 7.1.
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount of equity
securities that a listed company can issue or agree to issue without the approval of its shareholders
over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start of that
period.
The issue of the Convertible Notes and the CDIs/Shares issued on conversion of those notes, does not
fit within any of these exceptions and would exceed the Company’s 15% placement capacity available
at the date that those Equity Securities are issued.
Accordingly, resolution 2 seeks Shareholder approval to issue the Convertible Notes and the
CDIs/Shares that will be issued on conversion of those notes, under and for the purposes of Listing
Rule 7.1.
If resolution 2 is passed, the issue of the Convertible Notes may proceed and will not impact the
Company’s placement capacity going forward.
If resolution 2 is not passed, the issue of the Convertible Notes will not be able to proceed.
Additional information required under ASX Listing Rule 7.3
The Company provides the following information in accordance with ASX Listing Rule 7.3:
a) up to a maximum of approximately £10,600,000 worth of Convertible Notes will be issued to
certain institutional investors with allocation of the Convertible Notes determined by the
Company in consultation with the Company’s corporate advisers including Bell Potter. This
includes AXA Health and Axia as noted in the table above;
Doctor Care Anywhere Group PLC
Company No. 08915336
ARBN 645 163 873
13-15 Bouverie Street, 2nd Floor
London EC4Y 8DP
b) the Convertible Notes will convert to CDIs/Shares issued on the same terms and conditions as
the Company’s existing CDIs/Shares;
c) a summary of the material terms of the Convertible Notes is set out in Schedule 1 to this
Notice of Meeting;
d) the issue of the Convertible Notes may result in the issue of a maximum of 231,788,288 CDIs
on full conversion of the Convertible Notes;
e) the issue of the Convertible Notes will raise up to approximately £10,600,000 for the
Company;
f) subject to Securityholder approval being obtained at this Meeting, the Convertible Notes will
be issued to investors within 5 business days of this Meeting and in any event no later than 3
months of the date of this Meeting;
g) the Company will receive a total of approximately £10,600,000 for the issue of the Convertible
Notes which will be used to refinance the AXA Loan, pay for transaction costs in relation to
the refinancing and the Convertible Note Placement and working capital;
h) the Convertible Notes will be issued to each investor under a subscription agreement
(Subscription Agreement) and pursuant to the terms of the Convertible Note Instrument. A
summary of
Share your feedback
Discover